CA
NZ
UK
AU
IND
US
Cintas Corp saw its valuation climb as two prominent research houses lifted the price target to $230, prompting the stock to rally to $206.25, a gain of 7.22%. The upward revision follows strong recent results and aligns with fresh interest from institutional investors, notably …
The Goldman Sachs Group, Inc. has issued $9,000,000 in callable fixed rate notes due July 17, 2031, with an annual interest rate of 5.00%, according to a pricing supplement dated July 16, 2026. The notes carry redemption options beginning July 17, 2028, allowing the …
Alcoa’s stronger earnings are doing little to lift its stock, as sliding aluminum prices drag down mining equities and raise questions about the sector’s near-term resilience. The company’s latest financial results reflect better operational performance, but investors remain cautious amid weakening demand signals from …
Gold prices edged higher on Friday, but the rally was not enough to erase mounting concerns over inflation and potential interest rate hikes, leaving the precious metal poised for its first weekly loss in six weeks. The shift reflects broader market unease as investors …
Gold is heading for its most pronounced weekly decline in six weeks as investors grapple with renewed inflation fears and the prospect of higher interest rates. While the Iran war has stoked concerns about supply disruptions and rising energy costs, the dominant narrative in …
Wells Fargo’s latest analyst report sent ripples through financial markets, lifting State Street’s price target to $215 while signaling stronger loan demand across its banking network. The move underscores a broader shift in the sector, with improved profitability metrics and divergent outlooks for key …
The earnings surge complemented a $1.8 billion capital return package that combined dividends and share buybacks, reinforcing the firm’s commitment to shareholder value. Revenue expansion and tighter operating metrics propelled the results, while credit quality metrics remained solid. The company’s outlook now hinges on …
UBS reaffirmed its stance on Eli Lilly stock as part of its ongoing analysis of the pharmaceutical group’s recent purchase of ATAI. The bank’s recommendation remained unchanged, signaling confidence that the acquisition will enhance Lilly’s pipeline without altering the valuation framework. UBS’s own equity …
Investors should maintain market exposure but refine their strategies to focus on high-conviction opportunities, according to guidance from a leading Morgan Stanley advisor. The call for selectivity arrives as financial markets face heightened uncertainty, with advisors emphasizing the need to balance risk and opportunity. …
The insurer’s $10.04 per-share profit for the period ended June 30, 2026, nearly doubled the $5.41 consensus estimate, underscoring a sharp rebound in underwriting performance and investment returns.
Please wait processing your request...